European Archives - Page 131 of 1393 - European Medical Journal

Standard of Care: Real-world Needs and Real-world Stories in Parkinson’s Disease

The Bial symposium ‘Standard of care: Real-world needs and real-world stories in Parkinson’s disease’ at the 11th Annual Congress of the…

Lundbeck and Contera partner on RNA-targeted drug discovery

Lundbeck is partnering with Contera Pharma to accelerate RNA-targeted drug discovery for serious neurological conditions.

prostate cancer drug treatment

PARP Inhibitors Transform Prostate Cancer Treatment

Financial challenges, comorbidities, and drug interactions may limit access, while systemic inequities contribute to racial and ethnic disparities.

asthma

New Insights into Asthma: Pseudo Leukotrienes and Inflammation

The study found that urinary øLT levels were significantly elevated, four- to five-fold higher, in patients with severe asthma compared to healthy controls.

Processed Food Undermines Benefits of a Plant-Based Diet

Processed food level, not plant-based label, determines heart disease risk, according to new French longitudinal cohort research.

One in Three Europeans Cannot Identify Cystitis, Study Warns

A major European survey finds that one in three people cannot identify cystitis as a bladder infection and that half remain unaware women are most at risk.

ESMO Presidential Interview: Fabrice André

I went into cancer care and cancer research because, when I was a fellow, it was the medical specialty with the largest number of challenges…

New MRI Technique Detects Early Frontotemporal Dementia

A GENFI study reveals a new MRI method detects early frontotemporal dementia changes before symptoms or brain shrinkage.

The Obesity Puzzle in the Era of GLP-1s

In this series, host Saranya Ravindran speaks with Holly Wyatt about the evolving landscape of obesity treatment in the era of glucagon-like peptide-1 (GLP-1) medications.

medical conference

ESMO 2025: Positive Results from OptiTROP Lung04

Sacituzumab tirumotecan improves survival over platinum chemotherapy in EGFR‑mutated NSCLC, OptiTROP‑Lung04 finds.